Delivery Order SPE2DB20D9127-SPE2DB23FPQT0
Award Date
6/7/23
Potential Completion Date
6/8/23
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $3,785.80 for the provision of Nucala 100 mg/ml auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of January 12, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. It is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $11,357.40 with a firm fixed-price pricing type. The contract was awarded by the Defense Logistics Agency (DLA) to provide Nucala 100 mg/mL auto-injectors. The award is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $499,999,999 that allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,785.80 firm fixed-price delivery order is for Nucala 100 mg/mL auto-injectors. This is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a wide range of pharmaceutical products, including...
The Defense Logistics Agency (DLA) awarded a $11,357.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of Nucala 100 mg/mL auto-injectors. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,892.90 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors. The award is not associated with any set-aside designation. The contract is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to place firm...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current delivery order, valued at $13,250.30, is for the supply of the drug Nucala...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Firm Fixed Price Delivery Order valued at $1,892.90 for the supply of Nucala 100 mg/mL auto-injectors. The award was made by the Defense Logistics Agency (DLA), a defense agency, under the SPE2DB program, which is an Indefinite Delivery Contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. The contract is not designated as a set-aside. Through this...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,714.80 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors to support the medical needs of military healthcare facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,357.40, is for the delivery of Nucala 100 mg/mL auto-injectors to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides Nucala 100 mg/mL auto-injectors to the Defense Logistics Agency (DLA) under a firm fixed-price delivery order valued at $5,678.70. The contract has a period of performance through July 26, 2023, and does not have a set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support...